Ranked #3,131 of 8,699 institutional investors
Palo Alto Investors LP
Palo Alto, CA
$632M
US stock portfolio at live prices · today −$7.9M (−1.23%)
Live prices, last trade 12:52 PM ET
- Value at quarter end (Q3 2026)
- $672M
- Change from Q2 2026
- −$51.6M (−7.13%)
- Positions
- 48 · 3 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$45.2M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesINSM 10.2%PTCT 7.94%ACAD 6.85%BMRN 6.17%MIRM 5.96%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| INSM Insmed Incorporated | 443,645 | $64.3M | 10.2% | Added +7% |
| PTCT PTC Therapeutics, Inc. | 875,349 | $50.2M | 7.94% | Reduced −5% |
| ACAD Acadia Pharmaceuticals Inc. | 2,485,608 | $43.3M | 6.85% | Reduced −13% |
| BMRN BioMarin Pharmaceutical Inc. | 642,455 | $39.0M | 6.17% | Reduced −6% |
| MIRM Mirum Pharmaceuticals, Inc. | 387,314 | $37.6M | 5.96% | Added +11% |
| BIIB Biogen Inc. | 132,918 | $33.1M | 5.24% | Reduced −5% |
| UTHR United Therapeutics Corporation | 58,875 | $32.7M | 5.17% | Reduced −6% |
| TRAX First Tracks Biotherapeutics, Inc. | 741,097 | $31.5M | 4.98% | Added +23% |
| CDNA CareDx, Inc. | 424,601 | $30.0M | 4.75% | Reduced −20% |
| IRON Disc Medicine, Inc. | 396,529 | $29.7M | 4.70% | Reduced −5% |
| DYN Dyne Therapeutics, Inc. | 1,881,927 | $29.6M | 4.69% | Added +14% |
| ANAB AnaptysBio, Inc. | 595,264 | $27.9M | 4.42% | Reduced −1% |
| IOVA Iovance Biotherapeutics, Inc. | 3,471,456 | $24.4M | 3.86% | Reduced −34% |
| RARE Ultragenyx Pharmaceutical Inc. | 710,029 | $11.8M | 1.86% | Added +19% |
| CLDX Celldex Therapeutics, Inc. | 343,101 | $9.5M | 1.50% | Reduced −14% |
| ANNX Annexon, Inc. | 2,811,222 | $8.8M | 1.40% | Reduced −5% |
| TVTX Travere Therapeutics, Inc. | 158,946 | $7.7M | 1.22% | Reduced −5% |
| BCAX Bicara Therapeutics Inc. | 689,344 | $6.1M | 0.96% | Added +25% |
| AGIO Agios Pharmaceuticals, Inc. | 200,984 | $5.7M | 0.90% | Reduced −6% |
| SNDX Syndax Pharmaceuticals, Inc. | 596,356 | $5.3M | 0.84% | Reduced −31% |
| TSHA Taysha Gene Therapies, Inc. | 1,337,217 | $5.0M | 0.79% | Reduced −4% |
| ALGN Align Technology, Inc. | 31,389 | $4.9M | 0.78% | Unchanged |
| CMPX Compass Therapeutics, Inc. | 7,148,673 | $4.7M | 0.75% | Added +23% |
| CAPR Capricor Therapeutics, Inc. | 548,071 | $4.3M | 0.68% | Added +139% |
| ACRS Aclaris Therapeutics, Inc. | 1,156,396 | $4.0M | 0.63% | Reduced −28% |
| EW Edwards Lifesciences Corporation | 33,640 | $3.5M | 0.55% | Unchanged |
| NBIX Neurocrine Biosciences, Inc. | 18,117 | $2.8M | 0.44% | Unchanged |
| ORKA Oruka Therapeutics, Inc. | 25,563 | $2.4M | 0.38% | Reduced −24% |
| TARA Protara Therapeutics, Inc. | 1,035,964 | $2.3M | 0.37% | New |
| STOK Stoke Therapeutics, Inc. | 84,631 | $2.3M | 0.36% | Unchanged |
| SGMT Sagimet Biosciences Inc. | 250,000 | $2.2M | 0.36% | Unchanged |
| VSTM Verastem, Inc. | 325,480 | $2.1M | 0.34% | Added +5% |
| CTNM Contineum Therapeutics, Inc. | 220,226 | $1.9M | 0.31% | New |
| XENE Xenon Pharmaceuticals Inc. | 47,902 | $1.8M | 0.28% | Reduced −7% |
| XERS Xeris Biopharma Holdings, Inc. | 104,410 | $1.8M | 0.28% | Unchanged |
| PYXS Pyxis Oncology, Inc. | 864,277 | $1.6M | 0.25% | Unchanged |
| BNTX BioNTech SE | 19,614 | $1.6M | 0.25% | Unchanged |
| HUM Humana Inc. | 3,985 | $1.6M | 0.25% | Unchanged |
| CYTK Cytokinetics, Incorporated | 30,036 | $1.5M | 0.24% | Reduced −7% |
| ANL Adlai Nortye Group Ltd. | 149,490 | $1.3M | 0.21% | New |
| NUVB Nuvation Bio Inc. | 326,609 | $1.2M | 0.19% | Unchanged |
| CMPS COMPASS Pathways plc | 115,616 | $942K | 0.15% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 1,787 | $693K | 0.11% | Unchanged |
| BCYC Bicycle Therapeutics plc | 188,351 | $549K | <0.1% | Reduced −7% |
| INSP Inspire Medical Systems, Inc. | 8,772 | $486K | <0.1% | Unchanged |
| EHTH eHealth, Inc. | 1,431,535 | $460K | <0.1% | Reduced −3% |
| ABEO Abeona Therapeutics Inc. | 108,865 | $266K | <0.1% | Unchanged |
| ALDX Aldeyra Therapeutics, Inc. | 155,709 | $131K | <0.1% | Unchanged |